|
Category:cosmetic ingredient for skin conditioning
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Food Chemicals Codex Listed: | No |
Organoleptic Properties:
| Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | | cosmetic ingredient for skin conditioning |
| Recommendation for broussonetia kazinoki callus extract usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for broussonetia kazinoki callus extract flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | broussonetia kazinoki var. ruyangensis callus extract | | | broussonetia monoica callus extract | | | extract of a culture of the callus of broussonetia kazinoki, moraceae |
Articles:
| PubMed:Correction: De Novo Assembly of Expressed Transcripts and Global Transcriptomic Analysis from Seedlings of the Paper Mulberry (Broussonetia kazinoki x Broussonetia papyifera). |
| PubMed:Broussonetia kazinoki modulates the expression of VEGFR-2 and MMP-2 through the inhibition of ERK, Akt and p70S6K‑dependent signaling pathways: Its implication in endothelial cell proliferation, migration and tubular formation. |
| PubMed:Characterization of bionanocomposite films prepared with agar and paper-mulberry pulp nanocellulose. |
| PubMed:De Novo assembly of expressed transcripts and global transcriptomic analysis from seedlings of the paper mulberry (Broussonetia kazinoki x Broussonetia papyifera). |
| PubMed:A prenylated flavan from Broussonetia kazinoki prevents cytokine-induced β-cell death through suppression of nuclear factor-κB activity. |
| PubMed:Kazinol Q from Broussonetia kazinoki enhances cell death induced by Cu(II) through increased reactive oxygen species. |
| PubMed:Inhibitory effects of heartwood extracts of Broussonetia kazinoki Sieb on the development of atopic dermatitis in NC/Nga mice. |
| PubMed:New estrogenic compounds isolated from Broussonetia kazinoki. |
| PubMed:Tyrosinase inhibitory effects of 1,3-diphenylpropanes from Broussonetia kazinoki. |
| PubMed:Antihyperglycemic effect of stem bark powder from paper mulberry (Broussonetia kazinoki Sieb.) in type 2 diabetic Otsuka Long-Evans Tokushima fatty rats. |
| PubMed:Inhibitory effects of plant extracts on tyrosinase, L-DOPA oxidation, and melanin synthesis. |
| PubMed:Inhibition of nitric oxide production on LPS-activated macrophages by kazinol B from Broussonetia kazinoki. |
| PubMed:Studies on the constituents of Broussonetia species X. Six new alkaloids from Broussonetia kazinoki Sieb. |
| PubMed:Five new diprenylated flavonols from the leaves of Broussonetia kazinoki. |
| PubMed:The biosynthesis of broussonetines: origin of the carbon skeleton. |
| PubMed:Studies on the constituents of Broussonetia species VIII. Four new pyrrolidine alkaloids, broussonetines R, S, T, and V and a new pyrroline alkaloid, broussonetine U, from Broussonetia kazinoki Sieb. |
| PubMed:Studies on the constituents of Broussonetia species. VII. Four new pyrrolidine alkaloids, broussonetines M, O, P, and Q, as inhibitors of glycosidase, from Broussonetia kazinoki SIEB. |
| PubMed:Cytotoxic isoprenylated flavans of Broussonetia kazinoki. |
| PubMed:Studies on the constituents of Broussonetia species. III. Two new pyrrolidine alkaloids, broussonetines G and H, as inhibitors of glycosidase, from Broussonetia kazinoki Sieb. |
| PubMed:Studies on the constituents of Broussonetia species. II. Six new pyrrolidine alkaloids, broussonetine A, B, E, F and broussonetinine A and B, as inhibitors of glycosidases from Broussonetia kazinoki Sieb. |
|